Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Elan and Boehringer Ingelheim to codevelop antibody-based therapeutics

Feb. 9, 2011

Lundbeck is granted rights to several Cephalon products in Canada and Latin America

Feb. 8, 2011

Ansaris earns milestone payment from Ono Pharma with identification of kinase-related agent

Feb. 8, 2011

Optimer Pharma and Astellas enter agreement for antibiotic fidaxomicin

Feb. 8, 2011

Phosphagenics enters agreement to develop TPM-delivered antipsoriasis drug

Feb. 8, 2011

Progenics and Salix Pharma enter into license agreement for Relistor

Feb. 8, 2011

Lilly and JDRF to study beta-cell regeneration to treat type 1 diabetes

Feb. 7, 2011

Tacere Therapeutics achieves milestone under collaboration with Pfizer

Feb. 7, 2011

Galapagos and Merck & Co. agree to end strategic alliances

Feb. 7, 2011

Pfizer and Takeda sign copromotion agreements for rheumatoid arthritis products

Feb. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026